• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本大阪癌症生存率区域差异的时间变化(1997 - 2015年)

Temporal changes in regional variations in cancer survival rates in Osaka, Japan (1997-2015).

作者信息

Shimadzu Kato Mizuki, Morishima Toshitaka, Sakaniwa Ryoto, Nakata Kayo, Kuwabara Yoshihiro, Ikawa Toshiki, Iwaki Yoko, Miyashiro Isao

机构信息

Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Department of Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan.

出版信息

Sci Rep. 2025 Jan 31;15(1):3854. doi: 10.1038/s41598-025-88052-x.

DOI:10.1038/s41598-025-88052-x
PMID:39890938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11785978/
Abstract

The variation in survival rates among patients with cancer based on residential areas has become a significant concern globally. Japan's Basic Plan to Promote Cancer Control Programs (BPPCCP), implemented in 2007, aimed to reduce this variation by designating cancer care hospitals in each cancer medical area (CMA) where patients resided. From the Osaka Cancer Registry data, we extracted 407,489 patients aged 15-74 years with cancer who received treatment in Osaka Prefecture between 1997 and 2015 and analyzed regional variations in survival rates for each patient's residential CMA before and after the implementation of the BPPCCP. By standardizing the distribution of the patients' background factors (sex, age, stage, and socioeconomic status) to the distribution of the whole prefecture, 5-year relative survival rates for each CMA were calculated, and regional variations were assessed. Before BPPCCP, survival variation reached 2.00 percentage points (p-values < 0.05); post-BPPCCP, it decreased to 0.98 percentage points and was no longer significant. In conclusion, the introduction of the BPPCCP in 2007 may have reduced regional variation in the survival rate of patients with cancer in Osaka Prefecture. Measures such as the BPPCCP could potentially equalize the cancer care delivery system.

摘要

基于居住地区的癌症患者生存率差异已成为全球关注的重要问题。日本于2007年实施的《促进癌症控制计划基本方案》(BPPCCP)旨在通过在患者居住的每个癌症医疗区域(CMA)指定癌症护理医院来减少这种差异。我们从大阪癌症登记数据中提取了1997年至2015年间在大阪府接受治疗的407,489名15 - 74岁的癌症患者,并分析了BPPCCP实施前后每个患者居住CMA的生存率区域差异。通过将患者背景因素(性别、年龄、阶段和社会经济地位)的分布标准化到整个府的分布,计算了每个CMA的5年相对生存率,并评估了区域差异。在BPPCCP之前,生存率差异达到2.00个百分点(p值<0.05);在BPPCCP之后,差异降至0.98个百分点且不再显著。总之,2007年引入BPPCCP可能降低了大阪府癌症患者生存率的区域差异。像BPPCCP这样的措施可能会使癌症护理提供系统更加均衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d77/11785978/75a7501ed0a1/41598_2025_88052_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d77/11785978/6270c5344ddf/41598_2025_88052_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d77/11785978/75a7501ed0a1/41598_2025_88052_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d77/11785978/6270c5344ddf/41598_2025_88052_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d77/11785978/75a7501ed0a1/41598_2025_88052_Fig2_HTML.jpg

相似文献

1
Temporal changes in regional variations in cancer survival rates in Osaka, Japan (1997-2015).日本大阪癌症生存率区域差异的时间变化(1997 - 2015年)
Sci Rep. 2025 Jan 31;15(1):3854. doi: 10.1038/s41598-025-88052-x.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
Do Patients of Different Levels of Affluence Receive Different Care for Pediatric Osteosarcomas? One Institution's Experience.不同富裕程度的患者在小儿骨肉瘤治疗上是否得到不同的护理?一家机构的经验。
Clin Orthop Relat Res. 2025 Apr 1;483(4):748-758. doi: 10.1097/CORR.0000000000003299. Epub 2024 Oct 30.
5
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
6
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
The Perinatal Committee report: Review of the progress of obstetric healthcare in Japan.围产期委员会报告:日本产科医疗保健进展回顾
J Obstet Gynaecol Res. 2025 Jul;51(7):e16354. doi: 10.1111/jog.16354.
9
Transition of care for adolescents from paediatric services to adult health services.青少年医疗护理从儿科服务向成人健康服务的过渡。
Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD009794. doi: 10.1002/14651858.CD009794.pub2.
10
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

本文引用的文献

1
Regional Variability in Survival for Patients Diagnosed with Selected Central Nervous System Tumours in Canada.加拿大特定中枢神经系统肿瘤患者的生存率存在地域差异。
Curr Oncol. 2024 May 29;31(6):3073-3085. doi: 10.3390/curroncol31060234.
2
Japan's healthcare delivery system: From its historical evolution to the challenges of a super-aged society.日本的医疗服务体系:从其历史演进到超老龄社会的挑战
Glob Health Med. 2024 Feb 29;6(1):6-12. doi: 10.35772/ghm.2023.01121.
3
Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: A population-based study.
日本大阪女性乳腺癌 15 年生存率和条件生存率:一项基于人群的研究。
Cancer Med. 2023 Jun;12(12):13774-13783. doi: 10.1002/cam4.6016. Epub 2023 May 4.
4
Travel patterns of patients seeking cancer care during the COVID-19 pandemic: Multi-centre cohort study in Osaka, Japan.在 COVID-19 大流行期间寻求癌症治疗的患者的出行模式:日本大阪的多中心队列研究。
J Cancer Policy. 2023 Jun;36:100416. doi: 10.1016/j.jcpo.2023.100416. Epub 2023 Feb 24.
5
[Geographic information in National Cancer Registry data: Overseas examples and challenges in Japan].[国家癌症登记数据中的地理信息:海外实例及日本面临的挑战]
Nihon Koshu Eisei Zasshi. 2023 Mar 23;70(3):163-170. doi: 10.11236/jph.22-093. Epub 2023 Feb 10.
6
Socioeconomic disparities in cancer survival: Relation to stage at diagnosis, treatment, and centralization of patients to accredited hospitals, 2005-2014, Japan.癌症生存率的社会经济差异:与诊断时的分期、治疗以及患者向认证医院集中的关系,2005-2014 年,日本。
Cancer Med. 2023 Mar;12(5):6077-6091. doi: 10.1002/cam4.5332. Epub 2022 Oct 13.
7
Explaining regional variations in colon cancer survival in Ontario, Canada: a population-based retrospective cohort study.解释加拿大安大略省结肠癌生存的地区差异:基于人群的回顾性队列研究。
BMJ Open. 2022 Sep 19;12(9):e059597. doi: 10.1136/bmjopen-2021-059597.
8
Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data.标准化生存概率:一种用于报告生存数据回归模型的有用且信息丰富的工具。
Br J Cancer. 2022 Nov;127(10):1808-1815. doi: 10.1038/s41416-022-01949-6. Epub 2022 Sep 1.
9
Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England.英格兰地区肝癌发病率、诊断途径、治疗和生存情况的地域差异。
Br J Cancer. 2022 Mar;126(5):804-814. doi: 10.1038/s41416-021-01509-4. Epub 2021 Nov 26.
10
Regional variation in cancer survival in Norway.挪威癌症生存率的地区差异。
Cancer Epidemiol. 2021 Dec;75:102038. doi: 10.1016/j.canep.2021.102038. Epub 2021 Sep 24.